Navigation Links
Norma Smith and Dr. Steven A. Stuchin honored at 2008 Founders Gala for NYU Hospital for Joint Diseases
Date:10/27/2008

Proceeds to Support New Ambulatory Musculoskeletal Center

NEW YORK, Oct. 27 /PRNewswire/ -- On November 3, leaders of New York's philanthropic, business, government, medical and civic communities will gather together to honor renowned orthopaedic surgeon Dr. Steven A. Stuchin and long-serving board member and philanthropist Mrs. Norma Smith, at NYU Hospital for Joint Diseases' (NYUHJD) 2008 Founders Gala. This event at the Waldorf=Astoria will be emceed by Dr. Max Gomez, Emmy Award-winning Medical Correspondent for WCBS-TV.

Lifestyle icon Martha Stewart, one of Dr. Stuchin's many grateful patients, will salute the doctor in a special video presentation. NYUHJD Board Chair Robin Smith and Robert I. Grossman, the Saul J. Farber Dean and CEO of NYU Langone Medical Center, will share the special privilege of presenting Norma Smith with her award.

"Our honorees have both played critical roles in the transformation of NYU Hospital for Joint Diseases into the most preeminent musculoskeletal healthcare facility in the country," said David A. Dibner, Senior Vice President for NYUHJD Hospital Operations and Musculoskeletal Strategic Area. "Mrs. Smith has been a loyal board member and benefactor since 1983. Her extraordinary generosity has supported numerous NYUHJD initiatives that have enabled the hospital to expand its cutting-edge programs and innovative services."

Mr. Dibner continued, "It is only fitting that Dr. Steven A. Stuchin, one of the hospital's most gifted surgeons, be honored at this year's Gala. While he is renowned for his outstanding expertise in the surgical management of arthritis, he is also lauded for the high level of compassion and care he brings to his work. On behalf of NYU Hospital for Joint Diseases, we express our sincerest gratitude."

Proceeds from this year's Gala will raise funds for one of the most exciting and critical ventures for NYUHJD -- the new Ambulatory Musculoskeletal Center at 38th Street. The Ambulatory Musculoskeletal Center will be the first stand-alone orthopaedic facility in the United States to combine superb clinical outpatient care and advanced research at a single point of service. The Center's design will maximize the patient experience through rapid and efficient scheduling, one-stop shopping for all musculoskeletal clinical care and wellness services, and the integration of premium information technology, which will allow data exchange with musculoskeletal experts world-wide.

For information, contact Angeline Cheah at 212-404-4433 or visit http://www.med.nyu.edu/hjd


'/>"/>
SOURCE NYU Hospital for Joint Diseases
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Clinical depression linked to abnormal emotional brain circuits
2. Brain imaging reveals breakdown of normal emotional processing
3. Normal role for schizophrenia risk gene identified
4. Novadaq Resumes Normal Business Operations by Securing ICG for SPY
5. How Candida albicans transforms from its normally benign form into life-threatening form
6. Grant Supports Study of Abnormal Ring-Shaped Chromosomes
7. How shyness and other normal human traits became sickness
8. Key Cleaning Solutions Products Utilized to Combat Community Acquired - MRSA (CA-MRSA) Are Succeeding In Killing Superbugs Where Normal Cleaning Practices and Products Are Not
9. Bad Children Can Happen to Good Parents: A Survival Manual for Parents of Difficult Children by Norman E. Hoffman, Ph.D.
10. Normal tissue not spared in new forms of breast cancer radiotherapy
11. Abnormal immune cells may cause unprovoked anaphylaxis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... ... March 23, 2017 , ... The ... from the NCQA. The accreditation covers StayWell’s asthma, coronary artery disease, congestive heart ... granted to organizations that have excellent programs for the delivery and improvement of ...
(Date:3/23/2017)... ... March 23, 2017 , ... March 23, 2017 - ... to easily reprint customer invoices, bills, statements and other correspondence when they have ... needed to retrieve and print the documents and batch them for efficient handling. ...
(Date:3/23/2017)... OR (PRWEB) , ... March 23, 2017 , ... Sharon ... Water, Global Climate Change and Your Health on VoiceAmerica, recently talked on her program ... she also used the occasion to remind listeners of an important distinction. World Water ...
(Date:3/23/2017)... ... March 23, 2017 , ... Corra Group is ... competitive pricing. Verisys through its FACIS and other services maintains the ... actions. , “We are delighted to be able to offer these various products ...
(Date:3/23/2017)... ... March 23, 2017 , ... ... New MEDDEV 2.7/1 Rev. 4 Guidance, **An FDAnews Webinar**, April 4, 2017 ... will the new EU MDR language change the way manufacturers approach CERs? ...
Breaking Medicine News(10 mins):
(Date:3/23/2017)... 23, 2017  Cornerstone Pharmaceuticals, Inc., a ... milestone today.  Following successful End-of-Phase I (EOP1) ... and Drug Administration (FDA), the Company has ... path forward to conduct pivotal trials of ... acute myeloid leukemia (AML) and pancreatic cancer. ...
(Date:3/23/2017)... March 23, 2017 Piramal ... Limited, anuncia el nombramiento de Stuart E. ... plataforma de servicios integrados completa para su base ... cargo clave en el crecimiento y ejecución de ... responsable de impulsar todas las actividades de desarrollo ...
(Date:3/23/2017)... Merrimack Pharmaceuticals, Inc. (NASDAQ: MACK ) ... a Phase 1 study of MM-310 in solid tumors. ... novel taxane and targets the EphA2 receptor, a protein ... major tumor types, including prostate, ovarian, bladder, gastric, pancreatic ... study is an important step in evaluating MM-310,s safety ...
Breaking Medicine Technology: